Mast cell-IgE-and mast cell-structural cell interactions in allergic airway disease

Curr Drug Targets Inflamm Allergy. 2003 Dec;2(4):303-12. doi: 10.2174/1568010033484016.

Abstract

Allergic diseases like atopic rhinitis, bronchial asthma, and urticaria are prevalent and on the rise. Mast cells are known to play a central role in the immediate phase reaction of allergic diseases through the IgE-mediated release of a variety of chemical mediators like histamine, leukotrienes, and prostaglandins. On the other hand, T lymphocytes, basophils and eosinophils are thought to be responsible in inducing the late phase response. Yet, recent studies show that the mast cell cannot be simplistically assigned a role in the immediate phase allergic response, and that this cell plays a crucial role in ongoing allergic inflammation, including the development of hyper-responsiveness. In the present article, the author will try to discuss the integrated roles of mast cells in IgE-mediated allergic inflammation with specific emphasis on the roles of mast cell-IgE networking and mast cell-structural cell interactions in the late phase allergic response and chronic allergic inflammation.

Publication types

  • Review

MeSH terms

  • Asthma / pathology
  • Cell Adhesion Molecules
  • Cytokines / physiology
  • Humans
  • Hypersensitivity / immunology*
  • Hypersensitivity / pathology*
  • Immunoglobulin E / physiology*
  • Mast Cells / immunology*
  • Mast Cells / pathology*
  • Rhinitis, Allergic, Seasonal / pathology

Substances

  • Cell Adhesion Molecules
  • Cytokines
  • Immunoglobulin E